Neuroblastoma News

SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers (March 23, 2017)

People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy trial devoted to rare cancers. Despite their name,... Continue Reading

Unituxin® Approved for Treatment of Children with High-Risk Neuroblastoma (April 9, 2015)

The U.S. Food and Drug Administration (FDA) has announced the first-ever drug approval for the treatment of children with high-risk neuroblastoma. In clinical trials Unituxin® (dinutuximab) has improved survival among children with this type of cancer... Continue Reading

Hycamtin/Cyclophosphamide Delays Progression of Recurrent Neuroblastoma (September 13, 2010)

Children with recurrent or refractory neuroblastoma experienced an improvement in progression-free survival when treated with the combination of Hycamtin® (topotecan) plus cyclophosphamide; overall survival, however, was not improved compared with Hycamtin... Continue Reading

Neuroblastoma Survival has Improved (May 12, 2010)

Between 1979 and 2005, ten-year overall survival with neuroblastoma improved from 34.9% to 65%. The results of this study, conducted in Italy, were published in the Journal of Clinical Oncology. Neuroblastoma is a disease in which cancerous cells form... Continue Reading

Latest Neuroblastoma News By Stage


General Neuroblastoma

Hycamtin/Cyclophosphamide Delays Progression of Recurrent Neuroblastoma (September 13, 2010)

Children with recurrent or refractory neuroblastoma experienced an improvement in progression-free survival when treated with the combination of Hycamtin® (topotecan) plus cyclophosphamide; overall survival, however, was not improved compared with Hycamtin... Continue Reading

Neuroblastoma Survival has Improved (May 12, 2010)

Between 1979 and 2005, ten-year overall survival with neuroblastoma improved from 34.9% to 65%. The results of this study, conducted in Italy, were published in the Journal of Clinical Oncology. Neuroblastoma is a disease in which cancerous cells form... Continue Reading

More General Neuroblastoma